Dwight Moxie is CLO & GC of Revance Therapeutics, Inc.. Currently has a direct ownership of 137,815 shares of RVNC, which is worth approximately $354,184. The most recent transaction as insider was on Mar 18, 2024, when has been sold 8,125 shares (Common Stock) at a price of $5.04 per share, resulting in proceeds of $40,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K
0% 3M change
212.75% 12M change
Total Value Held $354,184

Dwight Moxie Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Open market or private sale
$40,950 $5.04 p/Share
8,125 Reduced 5.57%
137,815 Common Stock
Mar 15 2024
SELL
Payment of exercise price or tax liability
$17,325 $5.3 p/Share
3,269 Reduced 2.19%
145,940 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
15,143 Added 9.21%
149,209 Common Stock
Jan 31 2024
BUY
Grant, award, or other acquisition
-
90,000 Added 40.17%
134,066 Common Stock
Sep 06 2023
SELL
Open market or private sale
$187,660 $17.06 p/Share
11,000 Reduced 19.98%
44,066 Common Stock
Sep 05 2023
SELL
Open market or private sale
$424,821 $17.81 p/Share
23,853 Reduced 30.22%
55,066 Common Stock
Aug 11 2023
SELL
Payment of exercise price or tax liability
$181,384 $18.91 p/Share
9,592 Reduced 10.84%
78,919 Common Stock
Aug 11 2023
BUY
Grant, award, or other acquisition
-
19,346 Added 17.94%
88,511 Common Stock
May 15 2023
SELL
Open market or private sale
$739,404 $34.55 p/Share
21,401 Reduced 23.63%
69,165 Common Stock
Mar 15 2023
SELL
Payment of exercise price or tax liability
$224,664 $30.65 p/Share
7,330 Reduced 13.2%
48,217 Common Stock
Mar 09 2023
SELL
Open market or private sale
$584,288 $31.59 p/Share
18,496 Reduced 24.98%
55,547 Common Stock
Sep 22 2022
BUY
Grant, award, or other acquisition
-
42,349 Added 36.38%
74,043 Common Stock
Sep 14 2022
SELL
Open market or private sale
$297,770 $27.07 p/Share
11,000 Reduced 25.76%
31,694 Common Stock
Mar 15 2022
SELL
Payment of exercise price or tax liability
$80,687 $15.79 p/Share
5,110 Reduced 10.69%
42,694 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
42,349 Added 31.86%
90,566 Common Stock
Sep 27 2021
SELL
Open market or private sale
$50,250 $30.0 p/Share
1,675 Reduced 3.39%
47,804 Common Stock
Mar 15 2021
SELL
Payment of exercise price or tax liability
$79,890 $27.73 p/Share
2,881 Reduced 5.5%
49,479 Common Stock
Feb 02 2021
BUY
Grant, award, or other acquisition
-
19,346 Added 26.98%
52,360 Common Stock
Sep 30 2020
SELL
Payment of exercise price or tax liability
$106,493 $25.14 p/Share
4,236 Reduced 11.37%
33,014 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
-
12,250 Added 24.75%
37,250 Common Stock
DM

Dwight Moxie

CLO & GC
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC